What is Intervention Insights?
Intervention Insights, a subsidiary of NeoGenomics Bioinformatics, operates within the information technology sector, focusing on enhancing next-generation cancer care. Its core product, Trapelo, aims to streamline patient-based decision-making for physicians, laboratories, and payers by providing real-time, evidence-based information and transparency. The company also sponsors The Precision Medicine Podcast, a platform dedicated to accelerating the adoption of precision medicine in oncology.
How much funding has Intervention Insights raised?
Intervention Insights has raised a total of $11.4M across 2 funding rounds:
Series B
$7.2M
Private Equity
$4.2M
Series B (2011): $7.2M, investors not publicly disclosed
Private Equity (2017): $4.2M, investors not publicly disclosed
What's next for Intervention Insights?
The substantial enterprise-level funding and recent strategic investment indicate a strong growth phase for Intervention Insights. This capital infusion is likely to fuel further development of its Trapelo platform, expand its market reach, and potentially support strategic partnerships within the precision medicine ecosystem. The company appears poised to solidify its position as a key player in leveraging technology to advance cancer care.
See full Intervention Insights company page
